10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
The treatment of neuroinfectious diseases depends on the underlying cause and may involve antimicrobial agents, antiviral medications, or antifungal drugs. In Bacterial Meningitis, prompt administration of antibiotics is crucial to prevent severe complications such as brain damage or death. Antiviral Drugs play a key role in managing viral encephalitis, while antiparasitic and antifungal medications are employed for infections like cerebral toxoplasmosis or fungal meningitis. Complications of neuroinfectious diseases can be severe and may include long-term neurological sequelae, cognitive impairment, and, in some cases, chronic disability. Rehabilitation and supportive care are often integral components of managing complications and optimizing patient outcomes. Prevention strategies for neuroinfectious diseases include vaccination against specific pathogens known to cause these infections, such as the meningococcal vaccine, the Japanese encephalitis vaccine, or the varicella-zoster vaccine. Additionally, practicing good hygiene, avoiding exposure to vectors in endemic regions, and implementing public health measures contribute to preventing the spread of neuroinfectious diseases. Ongoing research in neuroinfectious diseases focuses on understanding the pathogenesis of these infections, developing novel diagnostic tools, and exploring innovative treatment approaches. The interdisciplinary collaboration between neurologists, infectious disease specialists, microbiologists, and public health experts is essential for advancing our knowledge and improving the management and prevention of neuroinfectious diseases.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria